Benzinga.com

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...
High Times

Beckley Foundation Announces LSD, Microdosing Research

A series of three new research projects announced this week will seek to illuminate our understanding of microdosing LSD. The research is being spearheaded by The Beckley Foundation and its founder, ...
Business Insider

Demand is on the rise for a nearly $7,000 luxury psilocybin magic mushroom retreat as the wellness industry flocks to psychedelic drugs — see what it's like inside

Beckley Foundation's psilocybin magic mushroom retreats are seeing an uptick in demand. Beckley Retreats' will accommodate 75 participants this year and about 300 people next year. Magic mushrooms are ...
Business Wire

First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant Depression

OXFORD, England--(BUSINESS WIRE)--Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric disorders by transforming psychedelics into effective ...
Business Wire

Beckley Psytech Successfully Completes Phase I Clinical Study of Lead Candidate BPL-003, a Novel Benzoate Formulation Of 5-MeO-DMT

OXFORD, England--(BUSINESS WIRE)--Beckley Psytech, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic ...
KTLA

Beckley Waves Celebrates a Year of Milestones, Including $3.3 Million in New Funding, 200 Retreat Participants, the Inaugural Cohort of Therapist Training, and the Acquisition ...

LONDON, March 05, 2024 (GLOBE NEWSWIRE) -- Beckley Waves, the first venture studio explicitly formed to build and invest in the thriving psychedelic ecosystem to advance mental health and well-being, ...